Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity
Journal of Surgical Oncology2016Vol. 114(7), pp. 838–847
Citations Over TimeTop 11% of 2016 papers
Gavitt A. Woodard, Jane C. Crockard, Carolyn Clary-Macy, Clara Zoon-Besselink, Kirk D. Jones, W. Michael Korn, Andrew H. Ko, Alexander Gottschalk, Stanley J. Rogers, David M. Jablons
Abstract
The hybrid minimally invasive Ivor Lewis esophagectomy approach results in low perioperative morbidity and mortality and is well tolerated after neoadjuvant chemoradiation. Good long-term overall survival rates likely resulted from combined concurrent neoadjuvant chemoradiation in the majority of patients, which did not impact the ability to safely perform the operation or postoperative complications rates. J. Surg. Oncol. 2016;114:838-847. © 2016 2016 Wiley Periodicals, Inc.
Related Papers
- → Optimum Treatment Strategy for Superficial Esophageal Cancer: Endoscopic Mucosal Resection versus Radical Esophagectomy(2001)160 cited
- → The Influence of Different Treatment Strategies on the Long-Term Prognosis of T1 Stage Esophageal Cancer Patients(2021)7 cited
- → Will Patients With Resectable Esophageal Cancer Be Spared Esophagectomy?(2019)1 cited
- An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards.(2006)
- → Effect of en bloc esophagectomy and total meso-esophagectomy on esophageal cancer patients: a systematic review and meta-analysis(2022)